Meramyl (Ramipril)

Ramipril is a prodrug that is converted to ramiprilat, which blocks the angiotensin‑converting enzyme (ACE). By inhibiting ACE, the conversion of angiotensin I to angiotensin II is reduced, leading to vasodilation, decreased aldosterone secretion, lower sodium retention, and ultimately reduced blood pressure and cardiac workload.

The appropriate dose of Meramyl is determined by the prescribing healthcare professional based on the individual’s medical condition, response to therapy, and renal function. Dosage may be started low and titrated upward, and patients should follow the exact instructions provided on the prescription label.

Ramipril is classified as pregnancy category D, indicating evidence of risk to the fetus; it should be discontinued as soon as pregnancy is recognized. Use during breastfeeding is not recommended because the drug can be excreted in milk and may affect the infant. Alternative therapies should be considered.

To place an order, submit an enquiry on the Meramyl product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Meramyl (ramipril) shares the core mechanism of ACE inhibition with other drugs in the class, such as enalapril or lisinopril, but it has a longer half‑life and may provide more consistent blood‑pressure control in some patients. Choice of agent often depends on individual tolerability, dosing convenience, renal function and physician preference.

Meramyl tablets should be stored at room temperature, below 25 °C, in the original blister pack or container to protect them from moisture and light. Keep the medication out of reach of children and do not use if the packaging is damaged or the tablets appear discolored.

Meramyl is taken orally, usually once daily, with or without food, as directed by the prescribing clinician. The tablet should be swallowed whole with a glass of water; it should not be crushed, chewed, or split unless specifically advised by a healthcare professional.

The most serious adverse reactions to ramipril include angioedema, which can cause swelling of the face, lips, tongue or airway and may be life‑threatening, as well as severe hyperkalemia, acute renal failure, and significant drops in blood pressure. Patients should seek immediate medical attention if they experience any of these symptoms.

Meramyl is contraindicated in patients with a known hypersensitivity to ramipril or any ACE inhibitor, in those with a history of angioedema related to ACE‑inhibitor therapy, and in pregnant women. Caution is also advised for individuals with severe renal impairment, hyperkalemia, or bilateral renal artery stenosis.